| Result of AGM | 15-May-2013 | 16:34 | RNS |
| AGM Statement | 15-May-2013 | 07:00 | RNS |
| First PointMan DNA enrichment products launched | 13-May-2013 | 07:00 | RNS |
| Publication of Annual Report & Notice of AGM | 15-Apr-2013 | 13:34 | RNS |
| Final Results | 18-Mar-2013 | 07:00 | RNS |
| Establishment of EKF Molecular & Acquisition | 04-Mar-2013 | 07:00 | RNS |
| Pre-close Trading Update | 18-Jan-2013 | 07:00 | RNS |
| Directors' Exercise of Options | 21-Dec-2012 | 15:53 | RNS |
| Holding(s) in Company | 17-Dec-2012 | 07:00 | RNS |
| Holding(s) in Company | 27-Nov-2012 | 16:32 | RNS |
| Issue of Equity | 09-Nov-2012 | 07:00 | RNS |
| Half Yearly Report | 24-Sep-2012 | 07:00 | RNS |
| Trading Update | 05-Sep-2012 | 07:00 | RNS |
| HemoCue settlement agreement | 10-Aug-2012 | 07:00 | RNS |
| Licensing agreement for kidney markers | 17-Jul-2012 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 29.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 34.25 |
| 52 Week Low | 25.50 |
| Volume | 0 |
| Shares Issued | 272.72m |
| Market Cap | £79.09m |
| Beta | 0.23 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 3 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| No dividends found |
| CEO | Julian Baines |
| Finance Director | Richard Evans |
You are here: research